World News: 13:00 GMT Tuesday 28th May 2019. [Tyme Technologies, Inc. via Globe Newswire via SPi World News]
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the Jefferies Global Healthcare Conference in New York on June 7, 2019. The company will present their corporate overview for 2019 with special focus on advances in the science of cancer metabolism and clinical developments for their lead candidate SM-88 (racemetyrosine) in pancreatic, prostate and sarcoma cancers.
A live webcast of the presentation will be accessible on the events page under the Investor Relations section of Tyme Technologies’ website at .
The information contained in this press release is as of release date and TYME assumes no obligation to update forward-looking statements contained in this release as a result of future events or developments.
Contact:Ashley R. Robinson LifeSci Advisors, LLC 617-535-7742 firstname.lastname@example.org
Globe Newswire: 13:00 GMT Tuesday 28th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.